Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Crowley John J, Chief Financial Officer. Officer active across 2 companies, notably Fusion Pharmaceuticals Inc.. Aggregated, 4 filings have been published. Activity tracked since 2 February 2026. The latest transaction was filed on 2 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
John J. Crowley is the Chief Financial Officer of Fusion Pharmaceuticals Inc. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is crucial to support Fusion Pharmaceuticals' growth strategy.